Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcomeEmman Shubbar, Khalil Helou|BMC Cancer|2013Cited by 399
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinomaToshima Z. Parris, Khalil Helou|International Journal of Cancer|2013Cited by 69